Your browser doesn't support javascript.
loading
VAD Chemotherapy versus Bortezomib Containing Regimens as Remission Induction For ASCT in Multiple Myeloma: A Single Center Experience.
Yikilmaz, Aysun Sentürk; Akinci, Sema; Bakanay, Sule Mine; Dilek, Imdat.
Affiliation
  • Yikilmaz AS; Department of Hematology, Yildirim Beyazit University, Ankara 06010, Turkey.
  • Akinci S; Department of Hematology, Ataturk Training And Research Hospital, Ankara 06010, Turkey.
  • Bakanay SM; Department of Hematology, Yildirim Beyazit University, Ankara 06010, Turkey.
  • Dilek I; Department of Hematology, Yildirim Beyazit University, Ankara 06010, Turkey.
Int J Hematol Oncol Stem Cell Res ; 14(4): 248-256, 2020 Oct 01.
Article in En | MEDLINE | ID: mdl-33603986

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline Language: En Journal: Int J Hematol Oncol Stem Cell Res Year: 2020 Document type: Article Affiliation country: Turkey Country of publication: Iran

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline Language: En Journal: Int J Hematol Oncol Stem Cell Res Year: 2020 Document type: Article Affiliation country: Turkey Country of publication: Iran